Key Players
Competitive Landscape
Fungal protein competition includes biomass producers, yeast specialists, branded mycoprotein companies and formulation suppliers. Angel Yeast competes through dedicated yeast protein output, while Quorn brings mycoprotein into familiar retail foods. Cargill connects ABUNDA with feedstock and food application work. Formulation suppliers enter after the protein is selected and help manufacturers manage texture, nutrition, preservation and processing. Buyers do not evaluate these companies in the same way because their roles are different. A biomass producer is checked for strain identity and repeat supply, while a formulation supplier is checked for the result achieved in the finished product.
Company activity during 2026 moved towards convenient food formats, simpler recipes and wider nutrition channels. Quorn launched Lemon & Pepper Schnitzels in April and returned chilled mince with a four-ingredient recipe during the same month. Quorn also explained its Fusarium venenatum fermentation process in February 2026, giving buyers clearer information about how mycoprotein is produced. Glanbia reported revenue and volume growth in every business segment during the first half of 2026. These developments indicate that fungal protein is moving through retail products and nutrition portfolios, rather than remaining limited to fermentation trials and specialist alternatives.
Company developments mapped to drivers, trends and opportunities (2026-2036)
| Development | Driver | Trend | Opportunity |
|---|---|---|---|
| In August 2026, Glanbia reported revenue and volume growth across every business segment. | Nutrition customers are using more protein formats and occasions. | Ingredient suppliers are widening application and channel coverage. | Fungal proteins can enter broader nutrition development programs. |
| In April 2026, Quorn launched Lemon & Pepper Schnitzels for preparation in under 15 minutes. | Households need convenient protein formats for routine meals. | Mycoprotein is moving into air-fryer and meal-centre products. | Retail formats can increase exposure beyond meat-free specialists. |
| In April 2026, Quorn returned chilled mince with four ingredients and a cooking time below 10 minutes. | Buyers want simpler recipes without losing meal convenience. | Branded mycoprotein products are reducing recipe complexity. | Simple ingredient lists can support familiar family meals. |
| In February 2026, Quorn updated its explanation of Fusarium venenatum fermentation and product processing. | Unfamiliar protein sources require clear production information. | Brands are explaining organism identity and manufacturing more directly. | Clearer product context can support buyer understanding and trial. |
Angel Yeast and Cargill participate closer to manufacturing and protein commercialization, while Quorn shows how mycoprotein can be sold through routine meal products. Tate & Lyle, Corbion, Glanbia, Bunge, ADM and Kemin participate through formulation, nutrition, feedstock and customer channels.
Who leads the fungal protein market?
Public evidence does not establish one verified market-share leader within the defined fungal protein ingredient market. Direct protein producers and formulation companies have different revenue sources, due to which one comparable leadership measure is not available.
Which companies provide direct fungal or yeast protein access?
Cargill has a commercial route to ABUNDA mycoprotein, while Angel Yeast operates dedicated yeast protein capacity. Cargill connects feedstock and application development, whereas Angel Yeast controls direct manufacturing output and available volume.
Which firms support multiple customer applications?
Tate & Lyle, Corbion, Glanbia, ADM, Bunge and Kemin support food, beverage, nutrition or feed applications. Their market role is based on formulation work, feedstock access and customer channels instead of direct ownership of fungal biomass production.
What should buyers evaluate before approving a supplier?
Buyers should first check organism identity, safety status, protein composition and the manufacturing process used for each batch. Taste, process stability, delivered cost and available volume should then be tested inside the intended recipe, because heat, shear and moisture can change the result.
Representative Company Overview
| Company | Positioning | Verified market-relevant capability |
|---|---|---|
| Tate & Lyle PLC | Global formulation supplier | Food formulation systems covering texture, mouthfeel, sweetening, and fortification. |
| Cargill, Incorporated | Global ingredient supplier | Commercial route to ABUNDA mycoprotein with application and feedstock support. |
| Angel Yeast Co., Ltd. | Yeast protein producer | Dedicated 11,000-ton annual yeast protein line started in November 2025. |
| Corbion N.V. | Fermentation and preservation supplier | Fermentation capability and preservation systems used in protein-rich foods. |
| Glanbia plc | Nutrition solutions supplier | Half year 2026 results reported revenue and volume growth in every business segment. |
| Bunge Limited | Food and feed channel supplier | Food, feed, and pet-food customer routes. |
| Archer Daniels Midland Company | Feedstock and biomanufacturing supplier | Fermentation feedstocks and biomanufacturing scale-up capability. |
| Kemin Industries, Inc. | Nutrition ingredient supplier | Yeast and animal-nutrition expertise with technical support. |
Research Methodology
The companies included in this section represent protein production, fermentation, formulation, nutrition, feed and customer-channel roles in fungal protein market. Public regulator records, company announcements, filings, product information and technical material are used to support company inclusion. Market estimates use the 2025 baseline, 2026 estimate and the 2026 to 2036 forecast period. Segment shares and country rates are proprietary analytical estimates and are not direct government measurements. Capability ratings consider documented activity, application coverage and geographic reach. Finished-food revenue and adjacent protein categories are excluded when they fall outside the stated market definition.
